Hillary H. Wu

A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma

David A. Smith, D. V. Von Hoff, L. Marton, 2020, Cancer Chemotherapy and Pharmacology.

Sequential interleukin 3 and granulocyte‐macrophage–colony stimulating factor therapy in patients with bone marrow failure with long‐term follow‐up of responses

R. Kurzrock, M. Talpaz, R. Champlin, 2003, Cancer.

Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer

Simin Hu, S. Vukelja, D. Richards, 2011, Investigational New Drugs.